Skip to main content
ES
v1.2
Log in
D

Dr Lal Pathlabs

DR LAL PATHLABSNSE
₹1,859.9-25.20 (-1.34%)as of 2026-10-16
Market Cap
₹31,170Cr.
P/E Ratio
55.4
P/B Ratio
12.40
EPS (TTM)
₹33.57
Day Range
₹1,851.9 – ₹1,907.9
Div Yield
0.73%
ROCE
28%
ROE
22.3%
52W Low: ₹1,27352W High: ₹2,039
Themes:🏥 Healthcare & Hospitals
Appears in 1 screen
🛡️Low-Volatility Defensives
74
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 11.0% a year over three years.
  • Debt is 0.08× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Dr_Lal_Pathlabs — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
5.3/ 10Overall
3/ 10Valuation
9/ 10Quality
4/ 10Fundamental
5/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 55.4P/E: 55.4 | P/B: 12.40
Growth
GrowingSales CAGR — 3Y: 11% · 1Y: 14%
Profitability
High MarginROCE: 28% | ROE: 22.3%

Key Metrics

Valuation
PEG Ratio 1.85
Price / Sales 10.78x
Price / FCF 67.3x
Book Value ₹150
Margins & returns
Operating Margin 29%
Net Margin 18.9%
Return on Assets 17.4%

Frequently Asked Questions

MarketsPortfolioChart